Completed × Has results × Fluorodeoxyglucose F18 × Clear all 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Phase 2 Completed
15 enrolled 7 charts
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Phase 2 Completed
56 enrolled 14 charts
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Phase 2 Completed
51 enrolled 14 charts
PET Scan in Treating Patients With Metastatic Prostate Cancer
Phase NA Completed
173 enrolled 9 charts
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Phase 2 Completed
46 enrolled 12 charts
Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma
Phase 2 Completed
29 enrolled 10 charts
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Phase 2 Completed
164 enrolled 7 charts
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
Phase NA Completed
10 enrolled 3 charts
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Phase NA Completed
15 enrolled 17 charts
PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer
Phase NA Completed
13 enrolled 5 charts
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer
Phase 2 Completed
20 enrolled 6 charts
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Phase 2 Completed
47 enrolled 8 charts
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Phase NA Completed
15 enrolled 10 charts
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Phase 1/2 Completed
25 enrolled 14 charts
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Phase 1/2 Completed
384 enrolled 23 charts
Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
Phase 2 Completed
19 enrolled 7 charts
18F-FSPG PET/CT for Cancer Patients on Therapy
Phase 2 Completed
7 enrolled 6 charts
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
Phase 2 Completed
59 enrolled 13 charts
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Phase 2 Completed
97 enrolled 35 charts
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
Phase 2 Completed
26 enrolled 23 charts
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
Phase 2 Completed
55 enrolled 7 charts
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Phase NA Completed
17 enrolled 6 charts
Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
Phase 2 Completed
60 enrolled 31 charts
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
25 enrolled 8 charts
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Phase 1/2 Completed
88 enrolled 18 charts
A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC
Phase 2 Completed
26 enrolled 10 charts
Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer
Phase 2 Completed
20 enrolled 7 charts
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Phase 2 Completed
55 enrolled 7 charts
FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer
Phase 2 Completed
16 enrolled 7 charts
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
Phase 2 Completed
6 enrolled 6 charts
Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes
Phase 2 Completed
18 enrolled 7 charts
17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
Phase 2 Completed
9 enrolled 8 charts